The trademark application ONCOLYTIC IMMUNOTHERAPY was filed by CG Oncology, Inc., a U.S. corporation (the "Applicant"). Application under examination.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 2, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products for the treatment of cancer
Pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders
Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors
Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases
Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing.
The mark was filed in class 42 with Pharmaceutical research and development and Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders..